Diabetes

• 

  Publication Venue For

  • 21-OR: Implementation of an Intensive Telehealth Intervention for Rural Patients with Uncontrolled Diabetes.  69. 2020
  • Erratum. National Institutes of Health–Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418–3428.  66:2531.1-2531. 2017
  • Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer..  66:1103-1110. 2017
  • Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes.  65:893-901. 2016
  • Erratum: Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture (Diabetes (2008) 57 (3045-3055)).  65:818. 2016
  • Semaphorin3a Promotes Advanced Diabetic Nephropathy.  64:1743-1759. 2015
  • With the Flow: Adaptation of beta-Cell Function to Glucose Fluxes After Bariatric Surgery.  62:3671-3673. 2013
  • Erratum: Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies (Diabetes (2013) 62 (3282-3291)).  62:3641. 2013
  • Comparison of Lipoprotein-Derived Insulin Resistance Score and Standard Measures of Insulin Sensitivity.  62:A167-A167. 2013
  • Direct Effect of Exenatide on Endothelial Function in Humans.  62:A260-A260. 2013
  • Effects of Exercise Amount and Intensity versus Lifestyle Intervention on Glucose Tolerance in Adults With Prediabetes-STRRIDE PD.  62:A184-A184. 2013
  • Effects of Exercise Amount and Intensity versus Lifestyle Intervention on Metabolic Syndrome in Adults With Prediabetes-STRRIDE PD.  62:A188-A188. 2013
  • Effects of Exercise Amount and Intensity versus a Lifestyle Intervention on Fasting Glucose in Adults With Pre-diabetes-STRRIDE-PD.  62:A186-A186. 2013
  • Ghrelin Signaling in the Central Nervous System and/or beta-Cells Is Important for the Regulation of Insulin Secretion and Glucose Tolerance in Mice.  62:A511-A511. 2013
  • Increased Muscle Mitochondrial Mass in MCK-PGC1 alpha Transgenic Mice Alters Metabolic Responses to Diet and Exercise Intervention But Does Not Improve Clinically Relevant Outcomes.  62:A15-A15. 2013
  • Neurally Induced Postprandial Insulin Secretion Is Enhanced Similarly in Patients With and Without Hypoglycemia after Gastric Bypass Surgery.  62:A39-A39. 2013
  • Decreased Bone Marrow Neuronal Support in Type 1 Diabetes Shifts Normal Hematopoiesis Towards the Generation of (C-C Motif) Receptor 2 (CCR2) Monocytes.  61:A69-A69. 2012
  • Diet Oleic Acid (OA) Improves Metabolic Risk Factors in Young Adults: Lipidomic Analysis of Sexually Dimorphic Responsiveness.  61. 2012
  • Psyllium Husk Attenuates Peak Post-Prandial Glucose and Insulin Levels in Euglycemic Subjects: A Meta-Analysis of Randomized, Controlled Clinical Trials.  61:A245-A245. 2012
  • Psyllium Husk Lowers Fasting Glucose and HbA1c in Populations With Elevated Fasting Blood Glucose: A Meta-Analysis of Randomized, Controlled Clinical Studies.  61:A258-A258. 2012
  • Transcriptome Analysis of Human Diabetic Kidney Disease.  60:2354-2369. 2011
  • Effects of Glucagon-Like Peptide-1 and Exendin-4 on Food Intake with and without DPP-4 Inhibition.  58:A395-A395. 2009
  • Exendin-4 Increases Blood Glucose Levels Acutely in Rats by Activation of the Sympathetic Nervous System.  58:A135-A136. 2009
  • Insulin Secretion Mediated by GLP-1 Action Is Enhanced Following Roux-en-Y Gastric Bypass Surgery.  58:A39-A40. 2009
  • beta-Cell Function in Adolescents Presenting with Type 2 Diabetes Is Impaired and Comparable to Newly Diagnosed Diabetic Adults.  58:A463-A463. 2009
  • Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase (Diabetes (2009) 58, (1766-1775)).  58:2425-. 2009
  • Response to comment on: dichiara et al. (2007) the effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study: Diabetes 56:3014-3019, 2007.  57. 2008
  • In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia..  56:656-665. 2007
  • Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta are protected against diet-induced obesity..  56:161-167. 2007
  • Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance.  55:2849-2855. 2006
  • ACE and ACE2 activity in diabetic mice..  55:2132-2139. 2006
  • Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokine-mediated cytotoxicity in rat islets and beta-cell lines..  55:1398-1406. 2006
  • Peptide-mediated targeting of the islets of Langerhans..  54:2103-2108. 2005
  • Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death..  53:2804-2814. 2004
  • An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans..  53:2190-2194. 2004
  • Increased expression of Gi-coupled muscarinic acetylcholine receptor and Gi in atrium of elderly diabetic subjects..  53:2392-2396. 2004
  • A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14..  53:821-829. 2004
  • Ceramide content is increased in skeletal muscle from obese insulin-resistant humans..  53:25-31. 2004
  • Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes..  53:179-184. 2004
  • Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells..  52:2959-2968. 2003
  • Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats..  52:2935-2942. 2003
  • Regulation and function of the muscle glycogen-targeting subunit of protein phosphatase 1 (GM) in human muscle cells depends on the COOH-terminal region and glycogen content..  52:2221-2226. 2003
  • Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy..  52:1423-1432. 2003
  • Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD mice..  52:1551-1556. 2003
  • Stimulus/secretion coupling factors in glucose-stimulated insulin secretion: insights gained from a multidisciplinary approach..  51 Suppl 3:S389-S393. 2002
  • Linkage and association with type 1 diabetes on chromosome 1q42..  51:3318-3325. 2002
  • While tinkering with the beta-cell...metabolic regulatory mechanisms and new therapeutic strategies: American Diabetes Association Lilly Lecture, 2001..  51:3141-3150. 2002
  • Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site..  51:2135-2140. 2002
  • Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose..  51:951-957. 2002
  • Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells..  51:901-909. 2002
  • A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone..  51:347-355. 2002
  • Amelioration of diabetes and remodeling of adipose tissue by PPAR gamma agonists: Possible roles for uncoupling proteins.  50:A522-A523. 2001
  • Diabetes increases the risk of hypertension in young, non-obese, urban and rural Chinese.  50:A216-A216. 2001
  • Hostility predicts fasting glucose, insulin, and risk for type 2 diabetes.  50:A85-A85. 2001
  • How are we doing? Achievement of therapeutic targets in patients with diabetes and acute coronary syndromes.  50:A425-A425. 2001
  • Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1..  49:1967-1977. 2000
  • The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells..  49:1477-1484. 2000
  • Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice..  49:1203-1208. 2000
  • Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity..  49:562-570. 2000
  • Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion..  49:424-430. 2000
  • Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia..  48:2022-2027. 1999
  • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat..  48:1415-1424. 1999
  • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154..  48:1473-1481. 1999
  • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function..  48:1020-1025. 1999
  • Overexpression of G11alpha and isoforms of phospholipase C in islet beta-cells reveals a lack of correlation between inositol phosphate accumulation and insulin secretion..  48:1035-1044. 1999
  • Mutational analysis of the coding regions of the genes encoding protein kinase B-alpha and -beta, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: lessons from a search for genetic variability of the insulin-stimulated glycogen synthesis pathway of skeletal muscle in NIDDM patients..  48:403-407. 1999
  • Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage..  47:1392-1398. 1998
  • Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis..  47:1114-1120. 1998
  • Leptin directly alters partitioning in skeletal muscle (vol 46, pg 1360, 1997).  46:1663-1663. 1997
  • Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice..  46:1516-1520. 1997
  • Leptin directly alters lipid partitioning in skeletal muscle.  46:1360-1363. 1997
  • Leptin directly alters lipid partitioning in skeletal muscle..  46:1360-1363. 1997
  • beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy..  46:1276-1280. 1997
  • Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression..  46:958-967. 1997
  • Regulation of insulin secretion from novel engineered insulinoma cell lines..  46:968-977. 1997
  • Fluorescent labeling of phosphoserines in tissue proteins..  46:766-766. 1997
  • Erratum: Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice (Diabetes (1997) 46 (1516-1520)).  46:1920. 1997
  • Pre-prandial insulin LisPro improves glucose control in patients with secondary sulfonylurea failure..  45:1061-1061. 1996
  • Effects of fasting, refeeding, and intraluminal triglyceride on proglucagon expression in jejunum and ileum..  45:434-439. 1996
  • Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide I..  44:1433-1437. 1995
  • EFFECT OF VITAMIN-E SUPPLEMENTATION ON DIET-INDUCED DIABETES.  44:A70-A70. 1995
  • PREVENTIVE AND THERAPEUTIC EFFECTS OF L-GLUTAMINE ON DIET-INDUCED DIABETES.  44:A8-A8. 1995
  • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse..  43:1457-1461. 1994
  • STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells..  43:1326-1333. 1994
  • Cellular engineering and gene therapy strategies for insulin replacement in diabetes..  43:341-350. 1994
  • CEPHALIC PHASE INSULIN RESPONSES ARE MEDIATED BY CHANGES IN GLUCOSE.  42:A253-A253. 1993
  • COMBINATION INSULIN AND SULFONYLUREA THERAPY IN INSULIN-REQUIRING NIDDM.  42:A55-A55. 1993
  • CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects..  40:1314-1318. 1991
  • Effect of somatostatin-28 on dynamics of insulin secretion in perfused rat pancreas..  40:1163-1169. 1991
  • Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice..  40:82-87. 1991
  • Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men..  39:1198-1202. 1990
  • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells..  39:634-638. 1990
  • Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures..  38:1534-1538. 1989
  • Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice..  38:1433-1438. 1989
  • Diet-induced type II diabetes in C57BL/6J mice.  37:1163-1167. 1988
  • Diet-induced type II diabetes in C57BL/6J mice..  37:1163-1167. 1988
  • Failure of genetically selected miniature swine to model NIDDM..  36:284-287. 1987
  • ALTERED ALPHA-ADRENERGIC RESPONSIVITY IN C576J MICE.  35:A19-A19. 1986
  • TYPE-A BEHAVIOR PATTERN AND GLYCEMIC CONTROL IN IDDM.  35:A110-A110. 1986
  • In vitro preparation of nonenzymatically glucosylated human transferrin, alpha 2-macroglobulin, and fibrinogen with preservation of function..  34:462-470. 1985
  • Behavioral manipulation of the diabetic phenotype in ob/ob mice..  33:616-618. 1984
  • Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding..  33:192-195. 1984
  • Effects of experimental diabetes on adrenergic and cholinergic receptors of rat myocardium..  32:881-886. 1983
  • THE EFFECTS OF RELAXATION ON GLUCOSE-TOLERANCE IN INSULIN DEPENDENT DIABETES.  32:A171-A171. 1983
  • The BB diabetic rat. Profound T-cell lymphocytopenia..  30:887-889. 1981
  • Ionic basis of phenytoin sodium inhibition of insulin secretion in pancreatic islets..  28:1077-1082. 1979
  • A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin release..  27:1027-1042. 1978
  • Pathology of diabetes mellitus..  2:180-183. 1953
  • 198-OR: The Stimulatory Effect of Glucagon on Insulin Secretion Is Glucose Dependent in Healthy Human Subjects 2021
  • 205-LB: HGFAC Is a ChREBP-Regulated Hepatokine That Enhances Glucose and Lipid Homeostasis 2021
  • 781-P: Beyond Glucosuria: Urine Metabolome Signature Associated with Dapagliflozin in Wild-Type Mice 2021
  • 1839-P: Glycemic Control Impacts Severity of Hepatic Fibrosis in NAFLD/NASH 2020
  • 1848-P: Insulin Sensitivity and Metabolic Profile of Subjects with Type 2 Diabetes and Nonalcoholic Steatohepatitis after Exposure to Cenicriviroc: A Subanalysis of the CENTAUR Study 2020
  • 526-P: Urine Tricarboxylic Acid Cycle Organic Anions and Progression of Diabetic Kidney Disease 2020
  • 1016-P: A Novel GLP-1 and FGF-21 Dual Agonist Drug Protects Mice from Obesity and Hyperglycemia 2019
  • 1148-P: Cenicriviroc Safety in over 1,200 Subjects 2019
  • 1164-P: Effects of Cenicriviroc in Adults with NASH on Inflammatory Cytokines and Metabolic Parameters 2019
  • 136-OR: Efficacy of Cenicriviroc (CVC) in Adults with NASH-Induced Liver Fibrosis 2019
  • 140-LB: NGM313, a Novel Activator of b-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects 2019
  • 175-LB: Effect of a Telemedicine Diabetic Foot Ulcer Intervention on Health and Well-Being: A Cluster Randomized Controlled Trial 2019
  • 2191-P: PPM1K Regulates ß-Cell Proliferation, Insulin Content, and GSIS 2019
  • 329-OR: Shared Medical Appointments (SMA) with Weight Management vs. SMA Alone for Overweight or Obese Patients with Type 2 Diabetes 2019
  • EXSCEL—Once-Weekly Exenatide Reduces Medical Resource Utilization in Patients with Type 2 Diabetes Mellitus 2018
  • Impact of SGLT2 Inhibitors (SGLT2i) on Cardiovascular (CV) Risk and Estimated Glomerular Filtration Rate (eGFR) in the EXSCEL Placebo Group 2018
  • Preoperative Hemoglobin A1c Predicts Postoperative Weight Loss following Bariatric Surgery in Patients with Diabetes 2018
  • Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) 2018
  • A Pilot Study of Potassium Supplements on Glucose Metabolism in African-American Adults with Prediabetes 2017
  • Beta-Cell Sensitivity to Incretin Infusions in Healthy Adults 2017
  • CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk 2017
  • Does Bariatric Surgery Build Better Beta Cells? Vertical Sleeve Gastrectomy Stimulates Autonomous Improvements to Islet Function in Mice 2017
  • Ghrelin Suppresses Insulin Secretion More Potently under Low Glucose than High Glucose in Rodents 2017
  • Glucagon Stimulates Insulin Secretion through Both Glucagon and GLP-1 Receptors 2017
  • Perioperative Steroid Use for Knee and Hip Surgeries Increases Rates of Hyperglycemia but Is Associated with Reduced Length of Hospital Stays 2017
  • The Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Dapagliflozin Causes Ketosis In Nondiabetic and Diabetic Mice 2017
  • Viral-Mediated GK Knockout in Specific Hypothalamic Nuclei Confirms Differential Regulation of Pancreatic Islet Physiology 2017
  • Baseline Characteristics of Patients Enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) 2016
  • Fox01 Promotes Glucose Intolerance in Liver-specific Insulin Receptor Knockout (LIRKO) Mice by Regulating ATGL-dependent Lipo lysis and Fatty Acid Oxidation 2016
  • Management of Inpatient Hypoglycemia: Improving Safety through The Joint Commission Standards 2016
  • Regulation of Carnitine Acetyltransferase by Lysine Acetylation 2016
  • Sweet Transitions: Coordinating Diabetes Care between Hospital and Primary Care Settings 2016
  • The Role of Anti-serpin Immunity in Pancreatic Islet Regeneration 2015
  • 10-Year Trends in Care and Outcomes of Medicare Patients with Type 2 Diabetes 2014
  • Challenges of Diabetes Care and Insulin Delivery in Nursing Home Facilities 2014
  • The Importance of Heart Failure on the Outcomes and Health Care Costs of Medicare Patients with Type 2 Diabetes 2014
  • Metformin (Met) Prevents Weight Gain in Youth on Second Generation Antipsychotics (SGA) 2013
  • T2D Genetic Risk Counseling & Testing in Primary Care 2013
  • Hyperglycemia during Critical Illness Predicts Future Diabetes 2012
  • The Role of GLP-1 Receptor Signaling in Metabolic Changes after Roux-en-Y Gastric Bypass in Diet Induced Obese Rats 2012
  • Changes and Correlations with PreDx (R) Diabetes Risk Score Following Brief Residential Behavioral Weight Loss 2011
  • Effects of Muscle Specific Deletion of Carnitine Palmitoyltransferase and Carnitine Acetyltransferase on Fuel Selection 2011
  • Highly Dynamic Cytotoxic T-Lymphocytes and Pancreatic Islet Allograft Rejection 2010
  • How Important Are Deep Verses Superficial Subcutaneous Fat as Predictors of Adverse Metabolic Parameters? 2010
  • Longitudinal Assessment of Beta-Cell Function in Adolescents Newly Diagnosed with T2DM Compared to Weight Matched Controls: Two Year Assessment 2010
  • Multiparity Programs Offspring To Have Increased Adiposity 2010
  • Postprandial Insulin Secretion and Clearance in Patients with Hyperinsulinemic Hypoglycemic Syndrome Following Gastric Bypass Surgery 2010
  • CD28/154 Blockade Disrupts the Development of Diabetogenic T Cells while Permitting Regulatory T Cell Expansion 2009
  • A description of the Camp Joslin's Wilderness Leadership Program 2008
  • Blocking CD28 or LFA-1, but not CD154, signaling results in abortive activation of antigen-stimulated T cells 2008
  • Effects of exercise amount and intensity on minimal model derived Disposition Index 2008
  • Ex-4 and the DPP-IV inhibitor vildagliptin have additive effects to suppress food intake in rodents 2008
  • Exercise-induced reductions in thigh intermuscular adipose tissue are associated with lipoprotein particle size improvements in men 2008
  • Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes 2008
  • Inactivity and exercise (aerobic versus resistance) effects on body weight and body composition 2008
  • Inactivity and exercise (aerobic versus resistance) effects on liver and visceral fat 2008
  • Intraindividual variation of the incretin-related insulin response during oral glucose tolerance test 2008
  • Metabolic crosstalk between human skeletal myocytes and co-cultured adipocytes 2008
  • Parental history of obesity is a stronger risk factor for elevated body mass index in more contemporary time periods 2008
  • Peripheral effects of Ex-4 and GLP-1 on anorexia and weight loss 2008
  • The effects of diet composition and weight loss on serum adiponectin 2008
  • Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretion 2007
  • Antagonists of the GLP-1 receptor, ex-9 and dHis-Ex, block GIP action in vitro but not in vivo 2007
  • Gender as moderator of inflammatory markers and risk of type 2 diabetes in apparently healthy subjects 2007
  • High monounsaturated fat and high carbohydrate diets are equally effective and acceptable in overweight and obese subjects with type 2 diabetes 2007
  • Lipid loading alters metabolic function of primary human adipocytes grown in culture 2007
  • Overweight youth: Low prevalence of glucose intolerance and diabetes 2007
  • Regulation of lipid deposition in primary myocytes of lean and obese subjects 2007
  • Scheduled feeding improves postprandial glucose tolerance 2007
  • Sensory neurons in the portal vein can access small molecules in circulation: Support for a neuro-endocrine mechanism of action of GLP-1 2007
  • Severity of illness is not a major determinant of hyperglycemia in critically ill patients 2007
  • The incretin effect in adolescents with type 2 diabetes is not impaired 2007
  • The role of glucagon-like peptide-1 to stimulate postprandial insulin secretion in type 2 diabetes 2007
  • Effect of endogenous GLP-1 on insulin secretion during oral glucose tolerance tests 2006
  • Impaired fasting glucose and cardiovascular disease: The Framingham heart study 2006
  • Improved glucose tolerance in meal-fed rats is not regulated by GLP-1 or GIP 2006
  • Infrequent abnormalities of carbohydrate metabolism despite high rates of obesity and insulin resistance in a longitudinal study of adolescents 2006
  • MAO-uVNTR is related to CNS serotonergic function, glucose metabolism, BMI, and hostility 2006
  • Randomized one-year comparison of high monounsaturated fat and high carbohydrate diets in subjects with type 2 diabetes 2006
  • Restoration of an acute insulin response to glucose (AIRg) in drug-naive patients with type diabetes (T2DM) by 3-month treatment with vildagliptin 2006
  • Stability of insulin secretion following islet autotransplantation 2006
  • Fatty acids suppress skeletal muscle GLUT4 gene expression and human GLUT4 promoter activity in rat L6 myocytes 2003
  • Assessment of insulin and C-peptide secretion after islet transplantation 2002
  • Islet transplantation: The NIH experience 2002
  • Engraftment and long-term survival of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154 (hu5c8) 1999